Also, Conley et al. found in a breast cancer cell line that anti-angiogenesis therapy caused an increase in ALDH1-positive cells, indicating that these cells were associated with resistance to therapy [49]. This evidence concerns the gene ALDH1A1 and breast carcinoma.